Detalhe da pesquisa
1.
Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse.
Mol Cell Proteomics
; 19(8): 1360-1374, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32451349
2.
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate Cancer.
J Urol
; 206(4): 952-959, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34032505
3.
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(3): 408-419, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30738780
4.
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases.
Prostate
; 79(14): 1683-1691, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31442327
5.
A Cost-Effectiveness Analysis of Nivolumab and Ipilimumab Versus Sunitinib in First-Line Intermediate- to Poor-Risk Advanced Renal Cell Carcinoma.
Oncologist
; 24(3): 366-371, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30710066
6.
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease.
J Urol
; 202(6): 1199-1208, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31188734
7.
Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib.
Oncologist
; 21(10): 1212-1217, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27382030
10.
GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.
J Urol
; 192(5): 1542-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24769028
11.
Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.
BMC Cancer
; 14: 528, 2014 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25047061
12.
Late relapse of testis cancer.
Curr Urol Rep
; 14(5): 518-24, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23839244
13.
Neoadjuvant 177Lu-PSMA-I&T Radionuclide Treatment in Patients with High-risk Prostate Cancer Before Radical Prostatectomy: A Single-arm Phase 1 Trial.
Eur Urol Oncol
; 6(2): 151-159, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36216740
14.
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors.
JAMA Netw Open
; 6(2): e230490, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821111
15.
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study.
Nutrients
; 15(16)2023 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37630724
16.
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis.
Front Oncol
; 13: 1151701, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293597
17.
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression.
J Clin Oncol
; 41(3): 629-639, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240478
18.
A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy.
Front Med (Lausanne)
; 10: 1221484, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840996
19.
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial.
J Clin Oncol
; 41(22): 3839-3850, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290035
20.
AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy.
Prostate
; 72(10): 1133-9, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22127895